Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 130 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Synthetic hypericin (SGX301; VIMRxyn) for cutaneous T‐cell lymphoma, unspecified	Hypericin (SGX301; HBP-347)	Cutaneous T-cell lymphoma (CTCL)	Haematological Cancer and Lymphomas	2017	View \| Download
Taselisib in Combination with Fulvestrant for Advanced ER Positive, HER2-negative Breast Cancer – Second Line After Aromatase Inhibitor Therapy	Fulvestrant (Faslodex) , Taselisib (GDC-0032; RG-7604)	Breast cancer	Breast Cancer	2017	View \| Download
Tendoncel for the treatment of tennis elbow	Tendoncel	Tendon injury	Musculoskeletal System	2017	View \| Download
Tocilizumab (RoACTEMRA) [subcutaneous injection with an auto injector device] for adult patients with moderate to severe active rheumatoid arthritis - after DMARD failure	Tocilizumab (Actemra; R1569; RoActemra)	Rheumatoid arthritis	Rheumatology	2017	View \| Download
Tocilizumab (RoActemra) for Adults with Systemic Sclerosis – Second Line	Tocilizumab (Actemra; R1569; RoActemra)	Systemic sclerosis	Dermatology , Respiratory System	2017	View \| Download
Tonogenchoncel-L (Invossa) Gene Therapy for Regeneration of Cartilage in Patients with Degenerative Arthritis or Osteoarthritis of the Knee	Tonogenchoncel-L (Invossa; TG-C)	Regeneration of cartilage	Musculoskeletal System	2017	View \| Download
Topsalysin for benign prostatic hyperplasia	Topsalysin (PRX 302)	Benign prostatic hyperplasia (BPH)	Men's Health	2017	View \| Download
Tralokinumab for severe, uncontrolled asthma	Tralokinumab (CAT-354; LP 0162)	Asthma	Respiratory System	2017	View \| Download
Triheptanoin (UX-007) for glucose transporter type 1 deficiency syndrome (de vivo disease) – first line	Triheptanoin (UX007; Dojolvi)	Glucose transporter type 1 deficiency syndrome	Endocrine Nutritional and Metabolic Disorders	2017	View \| Download
Ublituximab (TG-1101) in combination with umbralisib (TGR-1202) for chronic lymphocytic leukaemia	Ublituximab (TG-1101; LFB-R603) , Umbralisib (TGR-1202; RP-5264)	Chronic lymphocytic leukaemia (CLL)	Haematological Cancer and Lymphomas	2017	View \| Download